Research programme: somatostatin receptor subtype 4 agonists - Peptide Logic
Alternative Names: LA-SSTR4 agonists - Peptide LogicLatest Information Update: 28 Nov 2023
At a glance
- Originator Peptide Logic
- Class Analgesics; Antibodies; Immunoconjugates; Peptides
- Mechanism of Action Somatostatin receptor subtype 4 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for research development in Pain in USA (Parenteral)
- 04 Oct 2019 Peptide Logic receives phase-II SBIR grant from the National Institutes of Health for LA SSTR4 agonists development in Pain
- 04 Oct 2019 Early research in Pain in USA (Parenternal)